Latest Insights - page 60 | BiopharmaTrend

UCLA Health Initiates Clinical Trial for Personalized Cancer Vaccine Targeting Aggressive Brain Tumors in Youth

Researchers at UCLA Health's Jonsson Comprehensive Cancer Center have launched a pioneering clinical trial to evaluate the safety and efficacy of a personalized cancer vaccine for adolescents and young adults …

Continue ›››

Lantern Pharma Reports 86% Clinical Benefit in NSCLC Trial, Initial Patient Cohort

Lantern Pharma has announced positive preliminary results from the ongoing Phase 2 HARMONIC clinical trial, targeting never smokers with advanced non-small cell lung cancer (NSCLC) who have developed resistance to …

Continue ›››

How to Define Intelligence and Consciousness for In Silico and Organoid-based Systems?

A global initiative is underway to create consensus definitions for diverse intelligent systems, including AI, LLMs, and biological intelligences. Led by Cortical Labs, the biological computing startup known for "Dishbrain," …

Continue ›››

This Company Open Sources The Largest AI Foundation Models for Pathology

Paige, an AI-powered pathology solutions provider, has announced the open-source release of its AI models, Virchow and PRISM. Available on Hugging Face, these models are designed to aid researchers, diagnosticians, …

Continue ›››

Healx Secures $47 Million in Series C Funding to Advance Rare Disease Treatments

Healx, a clinical-stage biotechnology company specializing in rare diseases, has successfully raised $47 million in a Series C funding round. The R42 Group, based in Silicon Valley, and Atomico, a …

Continue ›››

Montara Therapeutics Secures $8 Million to Advance Brain-Targeting Drug Platform

Montara Therapeutics, Inc. has announced the successful completion of an $8 million seed financing round, led by SV Health Investors’ Dementia Discovery Fund and co-lead by Two Bear Capital. This …

Continue ›››

Polaroid Therapeutics and SFM Limited Collaborate to Combat Antimicrobial Resistance in Wound Care

Polaroid Therapeutics (PTx), a Swiss biotech start-up, and SFM Limited (SFM), a UK-based leader in fibre development, have announced a collaboration aimed at addressing antimicrobial resistance (AMR) through advanced wound …

Continue ›››

Engineered Brain Parasite Used for Therapeutic Delivery

A study published in Nature Microbiology details a new method for delivering therapeutic proteins to the brain using the parasite Toxoplasma gondii. This parasite, which naturally crosses the blood-brain barrier …

Continue ›››

Off-the-Shelf Stem Cell Therapy Reduces Pain by 58%, Regenerates Cartilage

A clinical trial of a novel off-the-shelf stem cell therapy for knee osteoarthritis has shown significant improvements in pain relief and joint function, offering hope for patients suffering from this …

Continue ›››

AI Biotech BioAge Initiates STRIDES Phase 2 Clinical Trial for Obesity Treatment

BioAge Labs, Inc. has announced the dosing of the first patient in the STRIDES Phase 2 clinical trial. This study aims to evaluate the efficacy of azelaprag, an oral small …

Continue ›››

D-Wave's New AI/ML Quantum Cloud Service Roadmap, Implications for Drug Discovery

D-Wave Quantum Inc., the world’s first commercial supplier of quantum computers, has announced an extension of its Leap quantum cloud service, aiming to bolster the integration of quantum computing with …

Continue ›››

4D Medicine Secures £3.4m to Advance Resorbable Biomaterial Technology

4D Medicine, a spin-out from the Universities of Birmingham and Warwick, has raised £3.4 million ($4.4 million) in a Series A investment round. The funding will enable the completion of …

Continue ›››